Pravin Dugel
Chief Executive Officer presso OCULAR THERAPEUTIX, INC.
Patrimonio netto: 8 M $ in data 31/03/2024
Profilo
Dr. Pravin U.
Dugel, MD, is a Chairman, President & Chief Executive Officer at Ocular Therapeutix, Inc., an Independent Non-Executive Director at Oculis Holding AG and a Professor at University of Southern California.
He is on the Board of Directors at Oculis Holding AG, ORBIS International, Inc., American Society of Retinal Specialists and EURETINA – Europäische Gesellschaft für Netzhautspezialisten.
Dr. Dugel was previously employed as a President & Director by IVERIC bio, Inc., an Independent Director by Aerpio Pharmaceuticals, Inc., a Managing Partner by Retinal Consultants of Arizona Ltd., a Chairman-Retina Subspecialty Day Board by American Academy of Ophthalmology, Inc., a Professor by Keck School of Medicine of USC, a Managing Partner by Retinal Research Institute LLC, a Member by Spectra Eye Institute, and a Clinical Professor by Usc Roski Eye Institute.
He also served on the board at Aerpio Therapeutics, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York and a graduate degree from David Geffen School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OCULAR THERAPEUTIX INC
0.58% | 22/02/2024 | 854 979 ( 0.58% ) | 8 M $ | 31/03/2024 |
Posizioni attive di Pravin Dugel
Società | Posizione | Inizio |
---|---|---|
OCULIS HOLDING AG | Director/Board Member | 01/04/2020 |
OCULAR THERAPEUTIX, INC. | Chief Executive Officer | 15/04/2024 |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
EURETINA – Europäische Gesellschaft für Netzhautspezialisten | Director/Board Member | - |
American Society of Retinal Specialists | Director/Board Member | - |
ORBIS International, Inc.
ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Director/Board Member | 27/09/2017 |
Precedenti posizioni note di Pravin Dugel
Società | Posizione | Fine |
---|---|---|
IVERIC BIO, INC. | President | 11/07/2023 |
AERPIO PHARMACEUTICALS | Director/Board Member | 26/08/2021 |
Retinal Consultants of Arizona Ltd.
Retinal Consultants of Arizona Ltd. Hospital/Nursing ManagementHealth Services Retinal Consultants of Arizona Ltd. operates as an ophthalmology clinic. The private company is based in Phoenix, AZ. | Corporate Officer/Principal | 01/01/2019 |
░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░ | - |
░░░ ░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Pravin Dugel
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
David Geffen School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
OCULIS HOLDING AG | Health Technology |
Aziende private | 11 |
---|---|
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
ORBIS International, Inc.
ORBIS International, Inc. Hospital/Nursing ManagementHealth Services ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY. | Health Services |
American Academy of Ophthalmology, Inc.
American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Commercial Services |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
American Society of Retinal Specialists | |
Retinal Consultants of Arizona Ltd.
Retinal Consultants of Arizona Ltd. Hospital/Nursing ManagementHealth Services Retinal Consultants of Arizona Ltd. operates as an ophthalmology clinic. The private company is based in Phoenix, AZ. | Health Services |
Aerpio Pharmaceuticals, Inc.
Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
EURETINA – Europäische Gesellschaft für Netzhautspezialisten | |
Spectra Eye Institute
Spectra Eye Institute Medical/Nursing ServicesHealth Services Spectra Eye Institute operates an eye care center. The private company is based in Sun City. The American company was founded by Pravin U. Dugel. | Health Services |
Usc Roski Eye Institute
Usc Roski Eye Institute Medical/Nursing ServicesHealth Services USC Roski Eye Institute operates eye care clinics. The private company is based in Arcadia. | Health Services |
Retinal Research Institute LLC |
- Borsa valori
- Insiders
- Pravin Dugel